The European Rare Diseases Research Alliance (ERDERA) has pre-announced its 2027 Joint Transnational Call, “Catalysing Collaborative Research for Recently Identified Rare Diseases”, expected to open on 1 December 2026.
This funding opportunity aims to support international, multidisciplinary research collaborations focusing on recently identified rare diseases that remain understudied, helping to build the scientific knowledge needed for future therapeutic development.
Supporting Research into Understudied Rare Diseases
The call will focus on rare diseases first reported in scientific literature on or after 1 January 2010, with an emphasis on four key research areas:
- Natural history studies and patient registries
- Identification and validation of biomarkers
- Development of computational, cellular or animal disease models
- Investigation of disease mechanisms
The initiative encourages collaboration between researchers, clinicians, institutions and patient organisations, with patient representatives expected to be actively involved from the proposal development stage.
Key dates
- 1 December 2026: Expected call opening
- 14 December 2026: Information webinar for applicants (15:00–16:00 CET)
- 1 February 2027: Planned pre-proposal submission deadline
- 24 June 2027: Provisional full proposal deadline
The call is expected to follow a two-stage application process, with funding decisions anticipated in October 2027.
Find out more
Interested applicants are encouraged to consult the official pre-announcement for eligibility requirements, participating countries, funding conditions and application procedures.
Discover the ERDERA 2027 Joint Transnational Call
Register for the information webinar
Please note that the information and deadlines are provisional and may be updated when the call officially opens.